GlassScriptPhysician profile
Katie L Madlen
NPI 1457977969
$11,537.98
in general payments reported to CMS, 2019-2025
31 companies · $530 in 2025
The $530 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,735 · 2022: $3,540 · 2023: $2,875 · 2024: $1,858 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,203 · Education: $59.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,203.38 |
| Education | $59.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,556.63 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $1,037.10 | 2021-2025 | Trintellix |
| Lundbeck LLC | $979.11 | 2021-2025 | Abilify Asimtufii, Rexulti, Abilify Maintena |
| Otsuka America Pharmaceutical, INC. | $952.00 | 2021-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $829.07 | 2021-2024 | Caplyta |
| Alkermes, INC. | $798.53 | 2021-2025 | Aristada, Lybalvi, Vivitrol |
| Teva Pharmaceuticals USA, INC. | $740.86 | 2021-2025 | Uzedy, Austedo Xr, Austedo |
| Supernus Pharmaceuticals, INC. | $635.46 | 2022-2024 | Qelbree, Qelbree |
| Bausch Health US, LLC | $626.82 | 2021-2024 | Aplenzin, Wellbutrin |
| Corium, LLC | $596.41 | 2022-2025 | Azstarys, Adlarity |
| Janssen Pharmaceuticals, INC | $387.97 | 2022-2025 | Spravato, Invega Sustenna |
| Sunovion Pharmaceuticals INC. | $300.86 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $294.99 | 2021-2023 | Ingrezza |
| Ironshore Pharmaceuticals INC. | $233.46 | 2021-2024 | Jornay Pm |
| Neos Therapeutics, LP | $209.85 | 2021-2024 | Adzenys Xr-Odt |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $206.86 | 2023 | Quviviq |
| Indivior INC. | $205.47 | 2021-2025 | Sublocade, Perseris |
| Tris Pharma INC | $158.37 | 2022-2025 | Dyanavel Xr |
| Almatica Pharma LLC | $142.69 | 2021-2024 | Loreev Xr, Sertraline Hcl |
| Arbor Pharmaceuticals, INC. | $134.23 | 2021 | |
| Axsome Therapeutics, INC. | $95.79 | 2022-2024 | Sunosi, Auvelity |
| Owp Pharmaceuticals, INC. | $66.47 | 2021-2022 | |
| Biogen, INC. | $61.12 | 2023-2024 | Zurzuvae |
| E.R. Squibb & Sons, L.L.C. | $52.81 | 2024 | Cobenfy |
| Braeburn INC. | $52.47 | 2024-2025 | Brixadi |
| Alfasigma USA, INC. | $51.23 | 2021 | |
| Harmony Biosciences LLC | $48.25 | 2024-2025 | |
| Eisai INC. | $29.49 | 2021 | |
| Jazz Pharmaceuticals INC. | $27.34 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.32 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Madlen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.